or Try an Advanced Search...

    Technical Analysis for ESPR - Esperion Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 2.34 5.41% 0.12
    ESPR closed up 5.41 percent on Monday, July 1, 2024, on 1.14 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical ESPR trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Calm After Storm Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish 5.41%
    Fell Below 50 DMA Bearish 5.41%
    Volume Surge Other 5.41%
    Wide Range Bar Range Expansion 5.41%
    Outside Day Range Expansion 5.41%
    Older End-of-Day Signals for ESPR ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    10 DMA Resistance about 9 hours ago
    Up 1 ATR about 10 hours ago
    Up 10% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ESPR Chart by TradingView
    Basic chart:

    Profile

    Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic therapy that is in pre-clinical trials to reverse the deleterious effects of atherosclerosis. The company is based in Plymouth, Michigan.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Diabetes Obesity Lipid Cardiology Cholesterol Lipoprotein Gabaa Receptor Positive Allosteric Modulators Low Density Lipoprotein Atherosclerosis Niacin

    Is ESPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 29 Notable analyst calls this week: Nike, Micron and FedEx among top picks
    Jun 28 PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
    Jun 28 Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
    Jun 20 Esperion closes down 16% following BofA downgrade
    Jun 20 Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Jun 17 Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?
    Jun 13 Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
    Jun 11 3 Penny Stocks to Buy if You Want to Spend Less and Earn More
    Jun 7 Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?
    Jun 6 Why Is Esperion Therapeutics (ESPR) Up 14.2% Since Last Earnings Report?
    See more ESPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.4
    52 Week Low 0.7
    Average Volume 8,741,749
    200-Day Moving Average 1.97
    50-Day Moving Average 2.30
    20-Day Moving Average 2.51
    10-Day Moving Average 2.34
    Average True Range 0.24
    RSI (14) 48.19
    ADX 23.59
    +DI 28.15
    -DI 19.52
    Chandelier Exit (Long, 3 ATRs) 2.40
    Chandelier Exit (Short, 3 ATRs) 2.77
    Upper Bollinger Bands 3.13
    Lower Bollinger Band 1.88
    Percent B (%b) 0.37
    BandWidth 50.04
    MACD Line -0.04
    MACD Signal Line 0.02
    MACD Histogram -0.0532
    Fundamentals Value
    Market Cap 418.68 Million
    Num Shares 179 Million
    EPS -2.27
    Price-to-Earnings (P/E) Ratio -1.03
    Price-to-Sales 4.49
    Price-to-Book 74.89
    PEG Ratio -4.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.76
    Resistance 3 (R3) 2.77 2.63 2.69
    Resistance 2 (R2) 2.63 2.53 2.63 2.67
    Resistance 1 (R1) 2.49 2.46 2.56 2.48 2.64
    Pivot Point 2.35 2.35 2.39 2.35 2.35
    Support 1 (S1) 2.21 2.25 2.28 2.20 2.04
    Support 2 (S2) 2.07 2.18 2.07 2.01
    Support 3 (S3) 1.93 2.07 1.99
    Support 4 (S4) 1.92